← Leaderboards
Maria C Carrillo
Indiana University Indianapolis
$19,827,813
Attributed
$78,658,024
Total exposure
8
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $17.9M · FY2017–25$20M$15M$10M$5M$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$78,658,024 · 8
By mechanism
U01$70,305,186 · 1
R56$7,654,317 · 1
R13$698,521 · 6
Top collaborators
- Liana G Apostolova9 shared
- Bradford C Dickerson9 shared
- Gil Dan Rabinovici9 shared
- Gladys E. Maestre5 shared
- Monica G Rivera-Mindt5 shared
- Robert W. Turner5 shared
- Igor Akushevich2 shared
- Percy Griffin2 shared
Most similar at Indiana University Indianapolis
Same institution · by research overlap
- Roland W. Herzog$25,146,618
- Loren J Field$21,917,203
- Victoria L Champion$18,228,183
- David W. Clapp$30,065,006
- Bradford C Dickerson$59,157,479
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposS DiseaseFutureDesignInnovationResearch PersonnelAmericanParticipantElderlySiteDementiaBrainClinical TrialsCognitiveMeetingsDiagnosisSymposiumBiological MarkersRecruitLate Onset Alzheimer DiseaseAge RelatedPatient PopulationBaseEvaluation
Grant awards (24)
Black Men's Brain Health and Aging, Alzheimer's Disease and Related Dementias: Life Course Perspectives$50,000
R13 · FY2025 · AG
Alzheimerâs Association International Conference (AAIC) Advancements: Toward Mitigation of Disparities in ADRD$1
R13 · FY2025 · AG · contact PI
Alzheimerâs Association International Conference (AAIC) Advancements: Towards Health Equity in Alzheimerâs andall other Dementias$66,755
R13 · FY2024 · AG · contact PI
Black Men's Brain Health and Aging, Alzheimer's Disease and Related Dementias: Life Course Perspectives$50,000
R13 · FY2024 · AG
Early Onset AD Consortium - the LEAD Study (LEADS)$13,904,119
U01 · FY2023 · AG
Black Male Brain Reserve, Resilience & Alzheimerâs Disease: Life Course Perspectives$49,750
R13 · FY2023 · AG
Early-onset Alzheimerâs and other dementia: From natural history to clinical trials$44,215
R13 · FY2023 · AG · contact PI
Promoting Diverse Perspectives: Addressing Health Disparities Related to Alzheimer's and other Dementias$49,985
R13 · FY2022 · AG · contact PI
Black Male Brain Reserve, Resilience & Alzheimerâs Disease: Life Course Perspectives$49,750
R13 · FY2022 · AG
Early-onset Alzheimerâs and other dementia: From natural history to clinical trials$44,215
R13 · FY2022 · AG · contact PI
Early Onset AD Consortium - the LEAD Study (LEADS)$16,618,207
U01 · FY2021 · AG
Early Onset AD Consortium - the LEAD Study (LEADS)$1,072,053
U01 · FY2021 · AG
Leveraging Existing Data and Analytic Methods for Health Disparities Research Related to Aging and Alzheimer's Disease and Related Dementias (ADRD)$50,000
R13 · FY2021 · AG
Promoting Diverse Perspectives: Addressing Health Disparities Related to Alzheimer's and other Dementias$49,985
R13 · FY2021 · AG · contact PI
Black Male Brain Reserve, Resilience & Alzheimerâs Disease: Life Course Perspectives$49,750
R13 · FY2021 · AG
Early-onset Alzheimerâs and other dementia: From natural history to clinical trials$44,215
R13 · FY2021 · AG · contact PI
Early Onset AD Consortium - the LEAD Study (LEADS)$15,954,813
U01 · FY2020 · AG
Leveraging Existing Data and Analytic Methods for Health Disparities Research Related to Aging and Alzheimer's Disease and Related Dementias (ADRD)$50,000
R13 · FY2020 · AG
Brain Aging, AD and Dementia in Low and Middle Income Countries (LMICs) and Low Resource Settings: Gender, Genetics, Risk Factors, Pathophysiology and Prevention$49,900
R13 · FY2020 · AG
Early Onset AD Consortium - the LEAD Study (LEADS)$11,820,016
U01 · FY2019 · AG
Early Onset AD Consortium - the LEAD Study (LEADS)$2,473,288
U01 · FY2019 · AG
Early Onset AD Consortium - the LEAD Study (LEADS)$176,937
U01 · FY2019 · AG
Early Onset AD Consortium - the LEAD Study (LEADS)$8,285,753
U01 · FY2018 · AG
Early Onset Alzheimer's Disease Consortium$7,654,317
R56 · FY2017 · AG